Olimel N7e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N7e provides amino acid supplementation for conditions where protein turnover is increased or intake is insufficient.

• Post‑operative recovery: helps maintain nitrogen balance and supports tissue repair.
• Chronic kidney disease: assists in managing essential amino acid loss.
• Severe malnutrition: contributes to rebuilding lean body mass.
• Inborn errors of metabolism: supplies missing amino acids for metabolic control.
• Critical illness (ICU): supports metabolic demands during catabolic stress.

• The amino acid blend supplies the building blocks required for protein synthesis, stimulates the mTOR pathway and enhances nitrogen retention, thereby supporting tissue growth and repair. Individual amino acids act as precursors for neurotransmitters, enzymes and immune modulators, contributing to overall metabolic homeostasis.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild stomach upset reported by some patients.
• Diarrhea: loose stools, especially with high‑dose regimens.
• Metallic taste: transient alteration in mouthfeel.
• Headache: occasional mild headache.
• Abdominal discomfort: cramping or bloating.
• Rash: mild skin irritation.

Serious or Rare Side Effects

• Hyperammonemia: elevated blood ammonia levels in susceptible individuals.
• Allergic reaction: hives, swelling, or anaphylaxis.
• Metabolic acidosis: rare disturbance in acid‑base balance.
• Severe electrolyte imbalance: uncommon but possible with large volumes.
• Hepatic dysfunction: rare liver enzyme elevation.
• Renal impairment worsening: potential in patients with pre‑existing kidney disease.

Before initiating Olimel N7e, consider patient‑specific factors and monitor relevant parameters.

• Renal function: assess creatinine clearance in patients with kidney disease.
• Hepatic function: evaluate liver enzymes if pre‑existing liver disorder exists.
• Metabolic status: monitor ammonia and acid‑base balance during high‑dose therapy.
• Allergies: verify no known hypersensitivity to any listed amino acid.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino acid preparations can influence the absorption or metabolism of certain drugs.

Major Interactions (Avoid)

• Levodopa: may compete for transport across the intestinal wall, reducing efficacy.
• Anticonvulsants (e.g., valproate): can alter plasma amino acid levels, affecting seizure control.

Moderate Interactions (Monitor Closely)

• Insulin or oral hypoglycemics: amino acids may affect glucose metabolism, requiring dose adjustments.
• Thyroid hormones: high protein load can modify hormone binding.
• Certain antibiotics (e.g., tetracyclines): chelation may reduce antibiotic absorption.
• Warfarin: protein intake changes can influence INR stability.